Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Graft Polymer (UK) PLC ( (GB:SVNS) ) has provided an announcement.
Solvonis Therapeutics PLC, a UK-based company, has announced a change in its voting rights structure due to an acquisition or disposal of voting rights by Spreadex LTD. The notification reveals that Spreadex LTD’s voting rights have decreased from 7.1213% to 4.1118%, indicating a significant shift in shareholder influence. This change may impact the company’s governance and decision-making processes.
More about Graft Polymer (UK) PLC
Average Trading Volume: 14,324,719
Technical Sentiment Signal: Sell
Current Market Cap: £7.68M
For a thorough assessment of SVNS stock, go to TipRanks’ Stock Analysis page.